tradingkey.logo
tradingkey.logo
Search

Fortrea Holdings Inc

FTRE
Add to Watchlist
19.170USD
+0.090+0.47%
Close 07-31 16:00ETQuotes delayed by 15 min
1.82BMarket Cap
LossP/E TTM

Fortrea Holdings Inc

19.170
+0.090+0.47%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+0.47%

5 Days

-1.79%

1 Month

+9.04%

6 Months

+13.70%

Year to Date

+11.13%

1 Year

+251.10%

Key Figures
18.800Open
19.380High
1.91MVolume
LossP/E TTM
16.59P/E Dynamic
--Dividend TTM
2.08%Turnover Ratio
19.080Prev. Close
18.210Low
27.03MTurnover
LossP/E Static
3.04P/B
0.00%Div Yield TTM
-15.40%ROA
18.67052wk High
0.82Volume Ratio
-328.50MNet Profit
92.20MShares
-4.8182EPS TTM
--Beta
-64.55%ROE
3.97052wk Low
6.13%Amplitude
17.63%Gross Margin
1.82BMarket Cap
1.54Reward/Risk
4.46%Risk Rate

TradingKey Stock Score of Fortrea Holdings Inc

Currency: USD Updated: 2026-07-31

Key Insights

Fortrea Holdings Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 61 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 20.65.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Fortrea Holdings Inc's Score

Industry at a Glance

Industry Ranking
61 / 385
Overall Ranking
136 / 4281
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Fortrea Holdings Inc Highlights

StrengthsRisks
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.72B.
Fairly Valued
The company’s latest PE is -3.98, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 98.32M shares, decreasing 20.39% quarter-over-quarter.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 68.09 shares of this stock.

Analyst Rating

Based on 11 analysts
Buy
Current Rating
20.850
Target Price
+8.76%
Upside Space

Fortrea Holdings Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 11 analysts
Buy
Current Rating
20.850
Target Price
+8.76%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Fortrea Holdings Inc
FTRE
11
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99

Indicators

Indicators
Sell(3)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.063
Buy
RSI(14)
58.498
Neutral
STOCH(KDJ)(9,3,3)
52.442
Sell
ATR(14)
1.074
High Vlolatility
CCI(14)
8.064
Neutral
Williams %R
55.224
Sell
TRIX(12,20)
0.674
Sell
StochRSI(14)
3.297
Oversold
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
19.710
Sell
MA10
19.170
Buy
MA20
18.448
Buy
MA50
16.934
Buy
MA100
13.911
Buy
MA200
13.639
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Fortrea Holdings Inc Info

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Ticker SymbolFTRE
CompanyFortrea Holdings Inc
CEOThakrala (Anshul)
Websitehttps://www.fortrea.com/

Shareholders

Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.95%
Goldman Sachs & Company, Inc.
8.39%
Corvex Management LP
4.77%
State Street Investment Management (US)
4.35%
Vanguard Capital Management, LLC
4.27%
Other
64.27%

FAQs

What is the current price of Fortrea Holdings Inc (FTRE)?

The current price of Fortrea Holdings Inc (FTRE) is 19.17.

What is the symbol of Fortrea Holdings Inc?

The ticker symbol of Fortrea Holdings Inc is FTRE.

What is the 52-week high of Fortrea Holdings Inc?

The 52-week high of Fortrea Holdings Inc is 18.67.

What is the 52-week low of Fortrea Holdings Inc?

The 52-week low of Fortrea Holdings Inc is 3.97.

What is the market capitalization of Fortrea Holdings Inc?

The market capitalization of Fortrea Holdings Inc is 1.77B.

Is Fortrea Holdings Inc (FTRE) currently rated as Buy, Hold, or Sell?

According to analysts, Fortrea Holdings Inc (FTRE) has an overall rating of Buy, with a price target of 20.65.

What is the Earnings Per Share (EPS TTM) of Fortrea Holdings Inc (FTRE)?

The Earnings Per Share (EPS TTM) of Fortrea Holdings Inc (FTRE) is -10.81.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.